Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “M-Protein”

91 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 91 results

Testing effectiveness (Phase 2)Study completedNCT04368988
What this trial is testing

Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle Vaccine With/Without Matrix-M Adjuvant

Who this might be right for
COVID-19
Novavax 1,419
Testing effectiveness (Phase 2)Ended earlyNCT03634800
What this trial is testing

Radiotherapy With Immunotherapy for Systemic Effect in Myeloma (RISE-M)

Who this might be right for
Multiple Myeloma
Weill Medical College of Cornell University 6
Not applicableLooking for participantsNCT06539832
What this trial is testing

Intestinal Flora and Immunity in Monoclonal Gammopathy Patients

Who this might be right for
Multiple MyelomaMGUSGut Microbiota+2 more
Zhujiang Hospital 300
Testing effectiveness (Phase 2)WithdrawnNCT05239975
What this trial is testing

The Immunogenicity and Safety of SCTV01C in Population Aged ≥12 Years and Previously Vaccinated With Inactivated COVID-19 Vaccine

Who this might be right for
COVID-19SARS-CoV2 Infection
Sinocelltech Ltd.
Testing effectiveness (Phase 2)UnknownNCT05324319
What this trial is testing

Homologous vs Heterologous Third Vaccination in Kidney Transplant Recipients Kidney Transplant Recipients

Who this might be right for
COVID-19
Medical University of Vienna 200
Large-scale testing (Phase 3)Study completedNCT04583995
What this trial is testing

A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United Kingdom

Who this might be right for
SARS-CoV-2 InfectionCOVID-19
Novavax 15,185
Not applicableStudy completedNCT02698878
What this trial is testing

Unloading Induced Effects on Local Glucose Uptake Into m. Soleus

Who this might be right for
Local Glucose UptakeGlucose Metabolism Disorders
DLR German Aerospace Center 13
Early research (Phase 1)UnknownNCT04836871
What this trial is testing

Double Filtration Plasmapheresis Combined With Chemotherapy

Who this might be right for
Multiple Myeloma
Fuling Zhou 20
Early research (Phase 1)Study completedNCT05132907
What this trial is testing

Safety and Immunogenicity of HDT-301 Targeting a SARS-CoV-2 Variant Spike Protein

Who this might be right for
SARS-CoV2 Infection
HDT Bio 48
Not applicableLooking for participantsNCT05384509
What this trial is testing

(COVID-19) Longitudinal Neutralizing Antibody Titers in Cancer Patients Receiving Different Anti-caner Therapies

Who this might be right for
Cancer
Chang Gung Memorial Hospital 320
Large-scale testing (Phase 3)Looking for participantsNCT07185997
What this trial is testing

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

Who this might be right for
Non-Small-Cell Lung CancerMetastatic Non-Small-Cell Lung CancerAdvanced Non-Small-Cell Lung Cancer+3 more
ArriVent BioPharma, Inc.
Not applicableLooking for participantsNCT06065852
What this trial is testing

National Registry of Rare Kidney Diseases

Who this might be right for
Adenine Phosphoribosyltransferase DeficiencyAH AmyloidosisAHL Amyloidosis+81 more
UK Kidney Association 35,000
Not applicableUnknownNCT05536700
What this trial is testing

Using Mass Spectrometry (EasyM) Detecting Minimal Residual Disease (MRD) in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China 67
Not applicableStudy completedNCT06055660
What this trial is testing

Moesin Expression in Clear Cell Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Sohag University 50
Testing effectiveness (Phase 2)UnknownNCT04730895
What this trial is testing

Investigating the Role of 13cis Retinoic Acid in the Treatment of COVID-19 and Enhancement of Its Spike Protein Based Vaccine Efficacy and Safety.

Who this might be right for
Covid19 Vaccine
Kafrelsheikh University 360
Testing effectiveness (Phase 2)UnknownNCT05238454
What this trial is testing

A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01C in Population Aged ≥18 Years and Previously Fully Vaccinated With COVID-19 Vaccine

Who this might be right for
COVID-19SARS-CoV-2 Infection
Sinocelltech Ltd. 600
Not applicableWithdrawnNCT05476822
What this trial is testing

Profiling Spike Protein Antibody Response Post COVID-19 Booster

Who this might be right for
COVID-19 BoosterSpike Protein IgG Antibody
David Grant U.S. Air Force Medical Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT06390865
What this trial is testing

Testing MLN0128 (TAK-228) as Potentially Targeted Treatment in Cancers With TSC1 or TSC2 Genetic Changes (MATCH - Subprotocol M)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmRefractory Lymphoma+2 more
National Cancer Institute (NCI) 49
Not applicableStudy completedNCT01383759
What this trial is testing

Bortezomib/Dexamethasone (BD), Followed By Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone For the Initial Treatment of Monoclonal Immunoglobulin Deposition Disease (MIDD) Associated With Multiple Myeloma and AL Amyloidosis

Who this might be right for
Light Chain Deposition Disease (LCDD or MIDD)Light Chain and Heavy Chain Deposition Disease (LHCDD or MIDD)Monoclonal Immunoglobulin Deposition Disease (MIDD)+1 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT01571726
What this trial is testing

Imaging Studies and the Development of Multiple Myeloma

Who this might be right for
Multiple MyelomaSmoldering Multiple MyelomaMonoclonal Gammopathy of Undetermined Significance
National Cancer Institute (NCI)
Load More Results
480
20